Publications for Stina Garvin
Co-author map based on ISI articles 2007-
Journal Articles
Fredrik Jerhammar, Rebecca Ceder, Stina Garvin, Reidar Grenman, Roland C Grafstrom and Karin Roberg
Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma
CANCER BIOLOGY and THERAPY, 2010, 10(12), 1244-1251.
Web of Science® Times Cited: 3 |
Alexander Törnroos, Stina Garvin and Hans Olsson
The number of identified lymph node metastases increases continuously with increased total lymph node recovery in pT3 colon cancer
ACTA ONCOLOGICA, 2009, 48(8), 1152-1156.
Web of Science® Times Cited: 12 |
Stina Garvin and Charlotta Dabrosin
In vivo measurement of tumor estradiol and Vascular Endothelial Growth Factor in breast cancer patients
BMC Cancer, 2008, 73(8), .
Web of Science® Times Cited: 12 |
Ulrika W. Nilsson, Stina Garvin and Charlotta Dabrosin
MMP‐2 and MMP‐9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells
Breast Cancer Research and Treatment, 2007, 102(3), 253-261.
Web of Science® Times Cited: 25 |
Stina Garvin, Karin Öllinger and Charlotta Dabrosin
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
Cancer Letters, 2006, 231(1), 113-122.
Web of Science® Times Cited: 102 |
Stina Garvin, Ulrika W. Nilsson, Fredrik R. M. Huss, Gunnar Kratz and Charlotta Dabrosin
Estradiol increases VEGF in normal human breast studied by whole-tissue culture
Cell Tissue Research, 2006, 325(2), 245-251.
Web of Science® Times Cited: 12 |
Stina Garvin, Ulrika W. Nilsson and Charlotta Dabrosin
Effects of estradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
British journal of cancer, 2005, 93(9), 1005-1010.
Web of Science® Times Cited: 38 |
Stina Garvin and Charlotta Dabrosin
Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo
Cancer research, 2003, 63, 8742-8748.
Web of Science® Times Cited: 67 |
Ph.D. Theses
Ph.D., Lic. Theses
